OnKure Therapeutics (OKUR)

Profile

Full Name

OnKure Therapeutics, Inc.

Ticker Symbol

OKUR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://onkuretherapeutics.com

Employees

46

Key Details

Price

$2.93(-2.33%)

Market cap

$401.51M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$15.28(-477.24% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.93
OKUR price is $2.93

30-Day Relative Volume

0.34
OKUR 30-day relative volume is 0.34

Price Performance

Price Most recent change

-2.33%
OKUR price was down -2.33% on Apr 16, 2025

Price YTD change

-65.93%
OKUR price is down -65.93% since January 1st

Price 1-year change

-82.24%
OKUR price is down -82.24% year-on-year

Price 3-year change

-88.64%
OKUR price is down -88.64% over the past 3 years

Price Range

Price All-time high

$171.80
OKUR price is currently -98.29% below its historical high of $171.80

Price 3-year low

$2.57
OKUR price is currently +14.01% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$401.51M
OKUR market capitalization is $401.51 million

Market cap 3-year change

-
OKUR market capitalization 3-year change is unknown

Market cap All-time high

$2.63B
OKUR market capitalization is currently -84.75% below its historical high of $2.63 billion

Market cap sector rank

66.78%
OKUR market capitalization is higher than 66.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
OKUR shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
OKUR shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.77
OKUR beta is 0.77

200-day SMA

$11.46
OKUR price is currently -74.44% below its 200-day simple moving average

50-day SMA

$4.69
OKUR price is currently -37.47% below its 50-day simple moving average

RSI

19.17
OKUR 14-day relative strength index is 19.17

Volume

0.34
OKUR 30-day relative volume is 0.34

ATR

$0.33
OKUR average true range is $0.33

10-day Historical Volatility

102.78%
OKUR 10-day historical volatility is 102.78%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
OKUR annual revenue value is unknown

Revenue Analysts estimate

$500.00K
OKUR annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
OKUR annual revenue 1-year change is unknown

Revenue Sector rank

-
OKUR annual revenue is unknown

EPS

EPS

-$15.28
OKUR annual earnings per share is -$15.28

EPS Analysts estimate

-$5.16
OKUR annual earnings per share is currently +196.12% higher than the consensus analysts' forecast

EPS 1-year change

-477.24%
OKUR annual earnings per share is down -477.24% year-on-year

EPS Sector rank

8.93%
OKUR annual earnings per share is higher than 8.93% of companies in Healthcare sector

Profit

Gross profit

-
OKUR annual gross profit value is unknown

Gross margin

-
OKUR annual gross profit margin value is unknown

Operating profit

-$54.39M
OKUR annual operating income is -$54.39 million

Operating margin

-
OKUR annual operating profit margin value is unknown

Net income

-$52.67M
OKUR annual net profit is -$52.67 million

Net margin

-
OKUR annual net profit margin value is unknown

Expenses

Total expenses

$54.39M
OKUR annual total expenses is $54.39 million

Operating expenses

$54.39M
OKUR annual total operating expenses is $54.39 million

Cost of goods sold

-
OKUR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$10.59M
OKUR annual SGA is $10.59 million

Depreciation and amortization

$662.00K
OKUR annual depreciation & amortization is $662.00 thousand

Interest expense

$300.00K
OKUR annual interest expense is $300.00 thousand

Income tax

-
OKUR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$52.37M
OKUR annual earnings before interest & taxes is -$52.37 million

EBITDA

-$51.71M
OKUR annual EBITDA is -$51.71 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$114.91M
OKUR annual total assets is $114.91 million

Non current assets

$1.90M
OKUR annual long term assets is $1.90 million

Current assets

$113.00M
OKUR annual total current assets is $113.00 million

Cash and cash equivalents

$110.76M
OKUR annual cash & cash equivalents is $110.76 million

Accounts receivable

-
OKUR annual accounts receivable value is unknown

Inventory

-
OKUR annual inventory value is unknown

Liabilities

Total liabilities

$11.08M
OKUR annual total liabilities is $11.08 million

Long term liabilities

$549.00K
OKUR annual total long term liabilities is $549.00 thousand

Current liabilities

$10.53M
OKUR annual total current liabilities is $10.53 million

Accounts payable

$2.97M
OKUR annual accounts payable is $2.97 million

Debt

Total debt

$1.08M
OKUR annual total debt is $1.08 million

Total debt 1-year change

+60.98%
OKUR annual total debt is up +60.98% year-on-year

Long term debt

$549.00K
OKUR annual long term debt is $549.00 thousand

Short term debt

$536.00K
OKUR annual short term debt is $536.00 thousand

Equity & Capital

Shareholders equity

$103.83M
OKUR annual stockholders equity is $103.83 million

Book value

$103.83M
OKUR annual book value is $103.83 million

Retained earnings

-$154.72M
OKUR annual retained earnings is -$154.72 million

Working capital

$102.47M
OKUR annual working capital is $102.47 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$51.12M
OKUR annual cash flow from operations is -$51.12 million

Cash from operations 1-year change

-47.97%
OKUR annual cash flow from operations is down -47.97% year-on-year

Cash from investing

$15.87M
OKUR annual cash flow from investing activities is $15.87 million

Cash from investing 1-year change

+6552.44%
OKUR annual cash flow from investing activities is up +6552.44% year-on-year

Cash from financing

$116.13M
OKUR annual cash flow from financing activities is $116.13 million

Cash from financing 1-year change

+118.6%
OKUR annual cash flow from financing activities is up +118.6% year-on-year

CAPEX

CAPEX

-
OKUR annual capital expenditures value is unknown

CAPEX 1-year change

-
OKUR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$51.17M
OKUR annual free cash flow is -$51.17 million

Free cash flow 1-year change

-47.07%
OKUR annual free cash flow is down -47.07% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
OKUR annual gross profit margin value is unknown

Operating margin

-
OKUR annual operating profit margin value is unknown

Net margin

-
OKUR annual net profit margin value is unknown

ROA & ROE

ROA

-45.84%
OKUR annual return on assets is -45.84%

ROE

-50.73%
OKUR annual return on equity is -50.73%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OKUR price to earnings ratio value is unknown

PE ratio Sector rank

-
OKUR price to earnings ratio is unknown

PB Ratio

PB ratio

3.87
OKUR price to book ratio is 3.87

PB ratio Sector rank

78.75%
OKUR price to book ratio is higher than 78.75% of companies in Healthcare sector

PS Ratio

PS ratio

-
OKUR price to sales ratio value is unknown

PS ratio Sector rank

-
OKUR price to sales ratio is unknown

Enterprise value

Enterprise value

$291.83M
OKUR enterprise value is $291.83 million

Enterprise value Sector rank

62.92%
OKUR enterprise value is higher than 62.92% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.91
OKUR EV/EBITDA is -4.91

EV/EBITDA Sector rank

18.61%
OKUR EV/EBITDA is higher than 18.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.73
OKUR annual current ratio is 10.73

Quick ratio

-
OKUR annual quick ratio value is unknown

Leverage

Debt to equity

0.01
OKUR annual debt to equity ratio is 0.01

Interest coverage ratio

-174.58
OKUR annual interest coverage ratio is -174.58

Risk & Stability

Piotroski F-Score

-
OKUR piotroski f-score value is unknown

Altman Z-Score

-
OKUR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 18, 25 HC Wainwright & Co.
Buy
Mar 11, 25 Oppenheimer
Outperform
Jan 28, 25 Jones Trading
Buy
Dec 5, 24 Leerink Partners
Outperform
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 10, 24 Oppenheimer
Outperform

Institutional Ownership

Similar stocks

PRTC logo
PureTech Health (PRTC)
SRDX logo
Surmodics (SRDX)
VERV logo
Verve Therapeutics (VERV)
PGEN logo
Precigen (PGEN)
ABVX logo
ABIVAX SA (ABVX)
AHG logo
Akso Health (AHG)
TMCI logo
Treace Medical Concepts (TMCI)
STOK logo
Stoke Therapeutics (STOK)
OMER logo
Omeros (OMER)
  • What is the ticker symbol for OnKure Therapeutics?
  • Does OnKure Therapeutics pay dividends?
  • What sector is OnKure Therapeutics in?
  • What industry is OnKure Therapeutics in?
  • What country is OnKure Therapeutics based in?
  • Is OnKure Therapeutics in the S&P 500?
  • Is OnKure Therapeutics in the NASDAQ 100?
  • Is OnKure Therapeutics in the Dow Jones?
  • When does OnKure Therapeutics report earnings?
  • Should I buy OnKure Therapeutics stock now?

What is the ticker symbol for OnKure Therapeutics?

The ticker symbol for OnKure Therapeutics is NASDAQ:OKUR

Does OnKure Therapeutics pay dividends?

No, OnKure Therapeutics does not pay dividends

What sector is OnKure Therapeutics in?

OnKure Therapeutics is in the Healthcare sector

What industry is OnKure Therapeutics in?

OnKure Therapeutics is in the Biotechnology industry

What country is OnKure Therapeutics based in?

OnKure Therapeutics is headquartered in United States

Is OnKure Therapeutics in the S&P 500?

No, OnKure Therapeutics is not included in the S&P 500 index

Is OnKure Therapeutics in the NASDAQ 100?

No, OnKure Therapeutics is not included in the NASDAQ 100 index

Is OnKure Therapeutics in the Dow Jones?

No, OnKure Therapeutics is not included in the Dow Jones index

When does OnKure Therapeutics report earnings?

The next expected earnings date for OnKure Therapeutics is May 30, 2025

Should I buy OnKure Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page